High GCLC levels were found in HCC tumor tissues and were associated with poor overall survival (OS) and disease-free survival (DFS) in patients after curative treatment [126], while MYC-driven inhibition of GCLC through miR-18a increased the sensitivity of liver cancer cells to oxidative stress [127]. This evidence concerns the gene GCLC and liver cancer.